Therapeutic Drug Monitoring Market in terms of revenue was estimated to be worth $1.8 billion in 2022 and is poised to reach $2.9 billion by 2027, growing at a CAGR of 9.6% from 2022 to 2027 according to a new report by MarketsandMarkets™. The growth of this market is majorly driven by the Increasing incidence of chronic and infectious diseases and growing awareness about early disease diagnosis. However, Alternatives to conventional TDM may challenge the growth of this market.
Attractive Opportunities in the Therapeutic Drug Monitoring Industry
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155350443
Browse in-depth TOC on "Antiepileptic Drug Monitoring Industry"
178 - Tables
50 - Figures
221 – Pages
Germany in European Antibiotic Therapeutic drug monitoring market to witness the highest shares during the forecast period.
The Europe Therapeutic Drug Monitoring Market is segmented into Germany, Italy, France, Spain, the UK, and the Rest of Europe. Germany is projected to occupy the highest share during the forecast period. The major factors contributing to the growth of this market are the rising geriatric population, increasing incidence of chronic and infectious diseases, rising healthcare expenditure, and increasing R&D investments.
Japan dominates the Asia Pacific Immunosuppressant Drug Monitoring industry
The APAC Therapeutic Drug Monitoring market is segmented into Japan, China, and India. In 2021, Japan accounted for the largest share of the Asian Therapeutic Drug Monitoring market. The large share of Japan can be attributed to the large geriatric population in the country, the rising prevalence of chronic medical conditions such as cancer, growing budgetary allocations for healthcare, and the presence of a well-developed healthcare system.
chemiluminescence immunoassays (CLIAs) in the product's immunoassay therapeutic drug monitoring segment to witness the highest growth as well as the largest share in the therapeutic drug monitoring market during the forecast period.
The market is divided into chemiluminescence immunoassays, colorimetric immunoassays, fluorescence immunoassays, radioimmunoassays, and other immunoassays based on the immunoassay. The chemiluminescence immunoassays segment is projected to grow at the highest CAGR during the forecast period because these assays are commonly used in TDM in either enzyme-amplified or direct chemiluminescence measurements.
Request 10% Customization:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=155350443
Antiarrhythmic Drug Monitoring Industry Dynamics:
Drivers:
- Importance of TDM in organ transplant procedures
- Use of TDM across various therapeutic fields
- Increasing preference for precision medicine
- Growing focus on R&D related to TDM
- Technological advancements
Restraints:
- Requirement of high capital investments
- Reluctance of small hospitals to offer TDM services
Opportunities:
- Increasing adoption in the treatment of autoimmune diseases
Challenges:
- Alternatives to conventional TDM
- Operational barriers faced in conducting TDM
Key Market Players:
The significant players in the Therapeutic Drug Monitoring industry are Abbott (US), Thermo Fisher Scientific (US), F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Healthineers AG (Germany), Danaher Corporation (US), Bio-Rad Laboratories (US), bioMérieux SA (France), Theradiag SA (France), Grifols S.A. (Spain), Exagen Inc. (US), R-Biopharm AG (Germany), ARK Diagnostics, Inc. (US), apDia Group (Belgium), Immundiagnostik AG (Germany), and Sekisui Medical Co. Ltd. (Japan).
Recent Developments:
- In May 22, Theradiag (France) Announced the launch of ez-Track1, a Point-of-Care Testing solution for TDM.
- In Jan 2021, Theradiag (France) Announced CE marking for four new i-Tracker test kits for biotherapy monitoring.
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 28)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
1.4 CURRENCY CONSIDERED
1.5 LIMITATIONS
2 RESEARCH METHODOLOGY (Page No. - 32)
2.1 RESEARCH DATA
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 MARKET SHARE ANALYSIS
2.5 ASSUMPTIONS
2.6 RISK ASSESSMENT
2.7 IMPACT OF RECESSION
3 EXECUTIVE SUMMARY (Page No. - 45)
FIGURE 11 THERAPEUTIC DRUG MONITORING MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 12 THERAPEUTIC DRUG MONITORING MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION)
FIGURE 13 THERAPEUTIC DRUG MONITORING MARKET, BY DRUG CLASS, 2022 VS. 2027 (USD MILLION)
FIGURE 14 THERAPEUTIC DRUG MONITORING MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 15 GEOGRAPHIC ANALYSIS: THERAPEUTIC DRUG MONITORING MARKET
4 PREMIUM INSIGHTS (Page No. - 49)
4.1 THERAPEUTIC DRUG MONITORING MARKET OVERVIEW
4.2 ASIA PACIFIC: THERAPEUTIC DRUG MONITORING MARKET, BY COUNTRY AND DRUG CLASS
4.3 THERAPEUTIC DRUG MONITORING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.4 THERAPEUTIC DRUG MONITORING MARKET, BY REGION (2022–2027)
4.5 THERAPEUTIC DRUG MONITORING MARKET: DEVELOPED VS. EMERGING ECONOMIES
5 MARKET OVERVIEW (Page No. - 53)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.3 TECHNOLOGY ANALYSIS
5.4 VALUE CHAIN ANALYSIS
5.5 SUPPLY CHAIN ANALYSIS
5.6 PORTER’S FIVE FORCES ANALYSIS
6 THERAPEUTIC DRUG MONITORING MARKET, BY PRODUCT (Page No. - 77)
6.1 INTRODUCTION
6.2 CONSUMABLES
6.3 EQUIPMENT
7 THERAPEUTIC DRUG MONITORING MARKET, BY TECHNOLOGY (Page No. - 84)
7.1 INTRODUCTION
7.2 IMMUNOASSAYS
7.3 CHROMATOGRAPHY-MS
8 THERAPEUTIC DRUG MONITORING MARKET, BY DRUG CLASS (Page No. - 95)
8.1 INTRODUCTION
8.2 ANTIEPILEPTIC DRUGS
8.3 ANTIARRHYTHMIC DRUGS
8.4 IMMUNOSUPPRESSANT DRUGS
8.5 ANTIBIOTIC DRUGS
9 THERAPEUTIC DRUG MONITORING MARKET, BY END USER (Page No. - 104)
9.1 INTRODUCTION
9.2 HOSPITAL LABORATORIES
9.3 COMMERCIAL & PRIVATE LABORATORIES
9.4 OTHER END USERS
10 THERAPEUTIC DRUG MONITORING MARKET, BY REGION (Page No. - 108)
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.3 EUROPE
10.4 ASIA PACIFIC
10.5 REST OF THE WORLD
11 COMPETITIVE LANDSCAPE (Page No. - 158)
11.1 OVERVIEW
11.2 STRATEGIES ADOPTED BY KEY PLAYERS
11.3 REVENUE SHARE ANALYSIS
11.4 MARKET SHARE ANALYSIS
11.5 COMPANY EVALUATION QUADRANT
12 COMPANY PROFILES (Page No. - 170)
12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))
13 APPENDIX (Page No. - 214)
13.1 INSIGHTS FROM INDUSTRY EXPERTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 CUSTOMIZATION OPTIONS
13.5 RELATED REPORTS
13.6 AUTHOR DETAILS
Report Link: ( Therapeutic Drug Monitoring Market )
About MarketsandMarkets™
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/therapeutic-drug-monitoring-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/therapeutic-drug-monitoring.asp
English
French (Français)
Spanish (Español)
Arabic
Portuguese (Português)
Deutsch
Turkish (Türk)
Dutch (Nederlands)
Italiano
Romaian (Română)
Português (Brasil)
Greek (Ελληνικά)